Research Grants

Research Grants


BCAN is committed to supporting bladder cancer research. From its inception, BCAN has cultivated a strong partnership with the leading members of the bladder cancer medical community to encourage collaboration among all the parties dedicated to the study of bladder cancer and its prevention, diagnosis and treatment. BCAN’s current research priorities are guided by the Bladder Cancer Research Network (BRCN) Management Committee. Our goal is to identify the best and most promising research that will provide the greatest opportunity to advance the understanding of bladder cancer and how to improve management and treatment of this disease. BCAN raises funds and awards grants to support early career investigators as well as innovative bladder cancer research to develop lifesaving treatments.

Information about applying for grants is available below. Please contact BCAN if you have any questions at grants@bcan.org.

Bladder Cancer Research Innovation Award

In 2014, BCAN announced the Bladder Cancer Research Innovation Award of $300,000 over a two-year period for an experienced investigator who will break new ground in the field of bladder cancer.  The aim of the award is to support exceptionally novel and creative projects with great potential to produce breakthroughs in the management of bladder cancer.

View the 2021 Bladder Cancer Research Innovation details and guidelines here

Award winners by year

  • 2020

    The Bladder Cancer Research Innovation Award

    Research: “Intravesical delivery of FC-enhanced CD40 against antibody for the treatment of bladder cancer.”

    Jeffrey Ravetch, MD, PhD

    Professor | Rockefeller University |

    Read More
  • 2019

    The Bladder Cancer Research Innovation Award

    Research: “Transdifferentiation of fibroblasts to urothelial progenitors for definitive urothelial replacement therapy in non-muscle invasive bladder cancer.”

    Philip Beachy, PhD

    Professor | Stanford University School of Medicine |

    Read More
  • 2018

    The Bladder Cancer Research Innovation Award

    Research: “Modeling bladder cancer metastasis using human patient-derived tumor organoids. ”

    Michael M. Shen, PhD

    Professor | Columbia University Irving Cancer Center |

    Read More
  • 2017

    The Bladder Cancer Research Innovation Award

    Research: “Proteogenomic characterization of MIBC to identify mechanisms of resistance and targets for therapy.”

    Seth Lerner, MD, FACS

    Chair of Urologic Oncology | Baylor College of Medicine |

    Read More
  • 2016

    The JPB Foundation Bladder Cancer Research Innovations Award

    Research: “Targeting FGFR3 in muscle-invasive bladder cancer.”

    David McConkey, PhD

    Director | Johns Hopkins Greenberg Bladder Cancer Institute |

    Read More
  • 2015

    James Family Foundation and Partner Fund Managment Bladder Cancer Research Innovations Award

    Research: “Epigenetic regulation of bladder cancer progression.”

    Cory Abate-Shen, PhD

    Professor of Urological Oncology | Columbia University Medical Center Associate Director of Translational Research | Herbert Irving Comprehensive Cancer Center |

    Read More
  • 2014

    The JPB Foundation Bladder Cancer Research Innovations Award

    Research: “Immune Characterization of High-Grade Bladder Cancer.”

    William Kim, MD

    Associate Professor | University of North Carolina at Chapel Hill |

    Read More

Young Investigator Awards

Raising the bar on research, BCAN launched its Young Investigator Awards in 2013. These one year $50,000 grants fund researchers who may be working in basic, translational, clinical, epidemiologic, bioengineering or any other scientific or research field, but are also working in a research environment capable of supporting transformational bladder cancer research. The program was seeded through a $250,000 challenge grant received from the Gerald C. McNamara and Renée K. Petrofes Charitable Fund.

“Since we began our Young Investigator Awards, BCAN has invested more than one million dollars to support early-career investigators. We are pleased to be able to help our promising, early-career research scientists who share in our urgent mission to improve bladder cancer outcomes.”

Andrea Maddox-Smith, Chief Executive Officer of BCAN.

View the guildelines for the 2021 BCAN Young Investigator and Patient-Centered Clinical Research Awards.

View the 2020 Awardees

Award winners by year

  • 2020

    The 2020 BCAN New Discoveries Young Investigator Award

    Research: “Defining NRF2 induced tumor invasion in bladder cancer.”

    Yuki Kita, M.D., Ph.D.

    University of North Carolina at Chapel Hill |

    Read More
  • 2020

    The BCAN New Discoveries Young Investigators Award

    Research: “Targeting regulatory B cells (Bregs) to improve anti-bladder cancer immunity.”

    Burles (Rusty) Johnson, M.D., Ph.D.

    Johns Hopkins University |

    Read More
  • 2020

    The BCAN New Discoveries Research Young Investigator Awards for Patient Centered Clinical Research

    Research: “Identifying Patient and Providers Factors Associated with Smoking Cessation.”

    Matthew Mossanen, M.D., MPH

    Brigham & Women’s Hospital |

    Read More
  • 2019

    The 2019 BCAN New Discoveries Young Investigator Award

    Research: “Recombinant CCL2 as a Novel Treatment Strategy for Bladder Cancer.”

    Neelam Mukherjee, MD

    University of Texas Health Science Center, San Antonio |

    Read More
  • 2019

    The 2019 BCAN New Discoveries Young Investigator Award

    Research: “Quantifying Risk and Resilience Among Patients with Bladder Cancer: A Novel Personalized, Comprehensive Risk Stratification Program.”

    Sarah Psutka, MD, MsC

    University of Washington, Seattle Cancer Care Alliance |

    Read More
  • 2019

    The BCAN New Discoveries Research Young Investigator Awards for Patient Centered Clinical Research

    Research: “Understanding the Burden and Impact of Financial Toxicity in Bladder Cancer—A Mixed Methods Study of Two Diverse Patient Populations.”

    Sumeet Bhanvadi, MD

    University of Southern California |

    Read More
  • 2018

    The 2018 BCAN Young Investigator Award

    Research: “Next-generation sequencing to enhance initial staging and dynamically monitor disease response in upper tract urothelial carcinoma (UTUC).”

    Philip Abbosh, MD, PhD

    | Fox Chase Cancer Center

    Read More
  • 2018

    The Palm Beach New Discoveries Young Investigators Award

    Research: “Modulation of regulatory T cells in the bladder tumor environment by anti-PD-L1 immunotherapy.”

    David Oh, MD, PhD

    | University of California, San Francisco

    Read More
  • 2018

    The Palm Beach New Discoveries Young Investigator Award for Patient Centered Clinical Research

    Research: “The implementation of nutrition education videos for patients undergoing radical cystectomy.”

    Eugene Lee, MD

    | University of Kansas Medical Center

    Read More
  • 2017

    The JPB Foundation Young Investigator Award

    Research: “Ascertaining the Role of Mutations in COMPASS-like Complex Members in the Development of Upper Tract Urothelial Carcinoma.”

    Byron Lee, MD, PhD

    Assistant Professor | Cleveland Clinic Foundation

    Read More
  • 2017

    Stephen Hale Gushée Young Investigator Award

    Research: “Defining the Immune Response to Chemotherapy and Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer.”

    Tracy Rose, MD, MPH

    Assistant Professor | UNC Chapel Hill

    Read More
  • 2016

    The JPB Foundation Young Investigator Award

    Research: “Role of antigen-specific immunity in BCG therapy for bladder cancer.”

    Niannian Ji, PhD

    University of Texas Health Science Center at San Antonio |

    Read More
  • 2016

    Stephen Hale Gushée Young Investigator Award

    Research: “Identifying Genomic Determinants of Chemoradiotherapy Response in Muscle-Invasive Bladder Cancer.”

    Kent William Mouw, MD, PhD

    Dana-Farber Cancer Institute |

    Read More
  • 2015

    Stephen Hale Gushée Young Investigator Award

    Research: “The Role of TP63 and ATDC in Invasive Bladder Cancers”

    Philip Palmbos, MD, PhD

    Clinical Lecturer | Clinical Lecturer |

    Read More
  • 2014

    BCAN Young Investigator Award

    Research: “The Role, Relationship and Therapeutic Potential of HAS2 and AGL in Bladder Cancer”

    Sunny Guin, PhD

    Postdoctoral Fellow | University of Colorado at Denver

    Read More
  • 2014

    The JPB Foundation Young Investigator Award

    Research: “Consequences of ARID1A Inactivation in Bladder Cancer.”

    Ryoichi Saito, MD, PhD

    Research Associate | University of North Carolina at Chapel Hill

    Read More
  • 2014

    The JPB Foundation Young Investigator Award

    Research: “Defining Immunotherapy Targets in Bladder Cancer Microenvironment Using Oncolytic Viruses.”

    Dmitriy Zamarin, MD, PhD

    Hematology/Oncology Fellow | Memorial Sloan-Kettering Cancer Center

    Read More
  • 2013

    BCAN Young Investigator Award

    Research: “Transcriptional Control of Bladder Cancer Tumorigenesis”

    David DeGraff, PhD

    Postdoctoral Fellow | Vanderbilt University Medical Center

    Read More
  • 2013

    James Family Young Investigator Award

    Research: “Identifying Predictors of Response to mTOR-targeted Therapies in Bladder Cancer”

    Gopa Iyer, MD

    Clinical Instructor | Memorial Sloan-Kettering Cancer Center

    Read More
  • 2013

    Raymond and Marie Floyd Family Young Investigator Award

    Research: “High resolution molecular analysis of CD47-mediated immune escape in bladder cancer”

    Debashis Sahoo, PhD

    Instructor | Stanford University

    Read More

John Quale Travel Fellowship Program

Started in 2009, the John Quale Travel Fellowship Program provides funding to defray travel-related costs for early career investigators interested in bladder cancer research to attend the annual Bladder Cancer Think Tank Meeting, a unique opportunity to meet and learn from leaders in the field. The primary mission of this meeting is to enhance collaboration among physicians and researchers who are dedicated to the prevention, diagnosis, and treatment of bladder cancer.  The Travel Fellowship Program seeks to engage more early-career individuals with interests related to bladder cancer including basic scientists, urologists, oncologists, and pathologists. 

Read about this year’s winners.

Learn more

Award winners by year

    • 2020

      • Nathan Brooks, MD | University of Texas MD Anderson Cancer Center
      • John Christin, Ms, PhD | Columbia University Medical Center
      • Carissa Chu, MD | The Regents of the University of California, San Francisco
      • Ali Khaki, MD | University of Washington Seattle Cancer Care Alliance
      • Richard Matulewicz, MD | New York University School of Medicine
      • Jeffrey Wong, MD, PhD | Memorial Sloan Kettering Cancer Center
    • 2019

      • Lee Hugar, MD | Pittsburgh Medical Center
      • Amy Lim, MD, PhD | University of Texas MD Anderson Cancer Center
      • Amy Luckenbaugh, MD | Vanderbilt University Medical Center
      • Swathi Ramakrishnan, MD | Health Research Incorporated, Roswell Park Comprehensive Cancer Center
      • Samuel Washington, MD | University of California, San Francisco
      • Nathan Wong, MD, FRCSC | Memorial Sloan Kettering Cancer Center
    • 2018

      • Arpita Roy, PhD | National Cancer Center
      • Nirmish Singla, MD | University of Texas Southwestern
      • Shawn Dason, MD | Memorial Sloan Kettering Cancer Center
      • Panagiotis Vlachostergios, MD, PhD | Weill Cornell Medicine
    • 2017

      • Neelam Mukherjee, PhD | University of Texas
      • Brian Winters, MD | University of Washington Urology
      • Vadim Koshkin, MD | Cleveland Clinic, Taussig Cancer Institute
      • Janet Baack Kukreja, MD, MPH | Anderson Cancer Center
    • 2016

      • Samuel Funt, MD | Memorial Sloan-Kettering Cancer Center
      • Matthew Mossansen, MD | Massachusetts
      • Tracy Rose, MD | University of North Carolina at Chapel Hill
      • Debasish Sundi, MD | University of Texas M.D. Anderson Cancer Center
    • 2015

      • Abdul R. Banday, Ph.D., M.S. | NIH NCI Division of Cancer Epidemiology and Genetics
      • Max Kates, M.D. | Johns Hopkins Medical Institutions
      • Huyen T. Nguyen, Ph.D. | The Ohio State University
      • Randy Sweis, M.D.  | The University of Chicago
    • 2014

      • Philip Ho, MD.  | University of Texas M.D. Anderson Cancer Center
      • Tim Lautenschlaeger, MD | The Ohio State University
      • Young Lee, PhD | National Cancer Institute, Urologic Oncology Branch
      • Anirban Mitra, MD, Ph.D | Center for Personalized Medicine, University of Southern California
    • 2013

      • Richard Bambury, MD, BCh, BAO | Memorial Sloan-Kettering Cancer Center
      • Sima Porten, MD, MPH | MD Anderson Cancer Center
      • Srinivas Vourganti, MD | National Cancer Institute
      • Daniel Willis, MD | MD Anderson Cancer Center
    • 2012

      • Arjun Balar, MD | New York University Cancer Center
      • Jeffrey Bassett, MD, MPH | Vanderbilt University Medical Center
      • Eugene Lee, MD | University of Texas MD Anderson Cancer Center
      • Armine Smith, MD  | National Cancer Institute
    • 2011

      • Meng Chen, PhD | University of Texas MD Anderson Cancer Center
      • Kenneth Nepple, MD | Washington University in St. Louis
      • Sandip Prasad, MD | University of Chicago
      • Steven Smith, MD, PhD | University of Michigan
    • 2010

      • Andrew Feifer, MD | Memorial Sloan-Kettering Cancer Center
      • Heather Honorѐ Goltz, PhD, LMSW | VA Health Services Research and Development Center of Excellence
      • William Brandt, PhD | Johns Hopkins University
      • Kilian Gust, MD | Vancouver Prostate Centre
    • 2009

      • Gayathri Chadalapaka, PhD | Texas A&M University
      • David DeGraff, PhD |  Vanderbilt University Medical Cancer
      • Peter O’Donnell, MD | University of Chicago
      • Amit Patel, MD | Cleveland Clinic